Conflicts of interest C.H.S., invited speaker and grant/research support Abbott, Janssen-Cilag, Schering-Plough, Serono, Wyeth; A.V.A., grant/research support Abbott, Janssen-Cilag, Schering Plough, Serono, Wyeth; J.N.W.N.B., advisory boards for Abbott, Janssen-Cilag, Novartis, Schering-Plough, Wyeth; grant/research support Abbott, Janssen-Cilag, Schering-Plough, Serono, Wyeth; A.D.B., advisory boards and grant/research support Janssen-Cilag, Schering-Plough, Serono, Wyeth; R.J.G.C., none; D.A.C., none; A.Y.F., consultant for Galderma, Novartis, Schering-Plough, Serono, Wyeth, Pfizer; joint copyright owner of the DLQI; C.E.M.G., advisory boards and invited speaker for Abbott, Janssen-Cilag, Merck-Serono, Novartis, Schering-Plough, UCB Pharma, Wyeth; grant/research support Amgen, Centocor, Merck-Serono, Wyeth; K.J., advisory boards for Abbott, Schering-Plough; educational support Merck-Serono; N.J.McH., advisory boards for Janssen-Cilag, Schering-Plough; grant/research support Abbott; K.E.McK., advisory boards for Abbott, Janssen-Cilag; N.J.R., advisory boards (nonpersonal) for Abbott, Basilea Pharmaceutica, Janssen-Cilag, Merck-Serono, Schering-Plough, Succinct Healthcare; grant/research support Stiefel Laboratories, AstraZeneca; A.D.O., advisory boards for Abbott, Merck-Serono, Schering-Plough; grant/research support Abbott, Janssen-Cilag, Serono, Wyeth. This is an updated guideline prepared for the BAD Clinical Standards Unit, made up of the Therapy & Guidelines Subcommittee (T&G) and the Audit & Clinical Standards Subcommittee (A&CS). Members of the Clinical Standards Unit are: H.K. Bell (Chairman T&G), L.C. Fuller (Chairman A&CS), N.J. Levell, M.J. Tidman, P.D. Yesudian, J. Lear, J. Hughes, A.J. McDonagh, S. Punjabi, S. Wagle, S.E. Hulley and M.F. Mohd Mustapa (BAD Clinical Standards Administrator and Information Scientist). Guidelines produced in 2005 by the British Association of Dermatologists; reviewed and updated June 2009.
British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
Article first published online: 20 OCT 2009
© 2009 The Authors. Journal Compilation © 2009 British Association of Dermatologists
British Journal of Dermatology
Volume 161, Issue 5, pages 987–1019, November 2009
How to Cite
Smith, C.H., Anstey, A.V., Barker, J.N.W.N., Burden, A.D., Chalmers, R.J.G., Chandler, D.A., Finlay, A.Y., Griffiths, C.E.M., Jackson, K., McHugh, N.J., McKenna, K.E., Reynolds, N.J., Ormerod, A.D. and (Chair of Guideline Group) (2009), British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. British Journal of Dermatology, 161: 987–1019. doi: 10.1111/j.1365-2133.2009.09505.x
- Issue published online: 20 OCT 2009
- Article first published online: 20 OCT 2009
- Accepted for publication 25 August 2009
Options for accessing this content:
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.